Functional Analysis of a Novel, Non-Canonical RPGR Splice Variant Causing X-Linked Retinitis Pigmentosa.
Samuel KollerTim BeltraminelliJordi MaggiAgnès WlodarczykSilke FeilLuzy BaehrChristina Gerth-KahlertMoreno MenghiniWolfgang BergerPublished in: Genes (2023)
X-linked retinitis pigmentosa (XLRP) caused by mutations in the RPGR gene is one of the most severe forms of RP due to its early onset and intractable progression. Most cases have been associated with genetic variants within the purine-rich exon ORF15 region of this gene. RPGR retinal gene therapy is currently being investigated in several clinical trials. Therefore, it is crucial to report and functionally characterize (all novel) potentially pathogenic DNA sequence variants. Whole-exome sequencing (WES) was performed for the index patient. The splicing effects of a non-canonical splice variant were tested on cDNA from whole blood and a minigene assay. WES revealed a rare, non-canonical splice site variant predicted to disrupt the wildtype splice acceptor and create a novel acceptor site 8 nucleotides upstream of RPGR exon 12. Reverse-transcription PCR analyses confirmed the disruption of the correct splicing pattern, leading to the insertion of eight additional nucleotides in the variant transcript. Transcript analyses with minigene assays and cDNA from peripheral blood are useful tools for the characterization of splicing defects due to variants in the RPGR and may increase the diagnostic yield in RP. The functional analysis of non-canonical splice variants is required to classify those variants as pathogenic according to the ACMG's criteria.
Keyphrases
- copy number
- early onset
- gene therapy
- peripheral blood
- clinical trial
- genome wide
- late onset
- high throughput
- rna seq
- single cell
- single molecule
- energy transfer
- randomized controlled trial
- study protocol
- transcription factor
- circulating tumor
- mass spectrometry
- amino acid
- circulating tumor cells
- atomic force microscopy
- optic nerve
- real time pcr